BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Gao C, Zhao HC, Li JT, Yao SK. Diabetes mellitus and hepatocellular carcinoma: Comparison of Chinese patients with and without HBV-related cirrhosis. World J Gastroenterol 2010; 16(35): 4467-4475 [PMID: 20845516 DOI: 10.3748/wjg.v16.i35.4467]
URL: https://www.wjgnet.com/1007-9327/full/v16/i35/4467.htm
Number Citing Articles
1
Chien-Yuan Chen, Sheng-Yi Huang, Aristine Cheng, Wen-Chien Chou, Ming Yao, Jih-Luh Tang, Woei Tsay, Wang-Huei Sheng, Hwei-Fang Tien, Chien-Wei Su. High Risk of Hepatitis B Reactivation among Patients with Acute Myeloid LeukemiaPLOS ONE 2015; 10(5): e0126037 doi: 10.1371/journal.pone.0126037
2
Hui Zhang, Chun Gao, Long Fang, Hong-Chuan Zhao, Shu-Kun Yao. Metformin and reduced risk of hepatocellular carcinoma in diabetic patients: a meta-analysisScandinavian Journal of Gastroenterology 2013; 48(1): 78 doi: 10.3109/00365521.2012.719926
3
Chun Gao, Long Fang, Jing-Tao Li, Hong-Chuan Zhao. Significance and prognostic value of increased serum direct bilirubin level for lymph node metastasis in Chinese rectal cancer patientsWorld Journal of Gastroenterology 2016; 22(8): 2576-2584 doi: 10.3748/wjg.v22.i8.2576
4
Wei-Shuo Zhang, Xiao-Ou Li, Hui Zhang, Chun Gao, Long Fang, Hua-Yuan Yang. <p>Increased Level of Systolic Blood Pressure in Hepatocellular Carcinoma Patients with Diabetes Mellitus</p>Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020; : 1979 doi: 10.2147/DMSO.S251943
5
Ambreen Ayub, Usman Ali Ashfaq, Asma Haque. HBV Induced HCC: Major Risk Factors from Genetic to Molecular LevelBioMed Research International 2013; 2013: 1 doi: 10.1155/2013/810461
6
KEISUKE AMANO, TAKUMI KAWAGUCHI, RYOKO KUROMATSU, ATSUSHI KAWAGUCHI, ICHIRO MIYAJIMA, TATSUYA IDE, TATSUYUKI KAKUMA, MICHIO SATA. Time trends of clinical characteristics in hepatocellular carcinoma patients with chronic hepatitis B virus infection: A field survey between 2000 and 2012Molecular and Clinical Oncology 2014; 2(6): 927 doi: 10.3892/mco.2014.398
7
Chun Gao, Long Fang, Hong-Chuan Zhao, Jing-Tao Li, Shu-Kun Yao. Potential role of diabetes mellitus in the progression of cirrhosis to hepatocellular carcinoma: a cross-sectional case-control study from Chinese patients with HBV infectionHepatobiliary & Pancreatic Diseases International 2013; 12(4): 385 doi: 10.1016/S1499-3872(13)60060-0
8
Cheng-Hao Su, Yong Lin, Lin Cai. Genetic Factors, Viral Infection, Other Factors and Liver Cancer: An Update on Current ProgressAsian Pacific Journal of Cancer Prevention 2013; 14(9): 4953 doi: 10.7314/APJCP.2013.14.9.4953
9
Chien-Yu Lin, Pratik Adhikary, Kun Cheng. Cellular protein markers, therapeutics, and drug delivery strategies in the treatment of diabetes-associated liver fibrosisAdvanced Drug Delivery Reviews 2021; 174: 127 doi: 10.1016/j.addr.2021.04.008
10
Yan-Gang Wang, Peng Wang, Bin Wang, Zheng-Ju Fu, Wen-Juan Zhao, Sheng-Li Yan, Zhengdong Zhang. Diabetes Mellitus and Poorer Prognosis in Hepatocellular Carcinoma: A Systematic Review and Meta-AnalysisPLoS ONE 2014; 9(5): e95485 doi: 10.1371/journal.pone.0095485
11
Chun Gao. Molecular pathological epidemiology in diabetes mellitus and risk of hepatocellular carcinomaWorld Journal of Hepatology 2016; 8(27): 1119-1127 doi: 10.4254/wjh.v8.i27.1119
12
Lingling He, Shuan Zhang, Xiaoli Liu, Yuyong Jiang, Xianbo Wang, Zhiyun Yang. HbA1c-Based Score Model for Predicting Death Risk in Patients with Hepatocellular Carcinoma and Type 2 Diabetes MellitusJournal of Diabetes Research 2017; 2017: 1 doi: 10.1155/2017/3819502
13
Axel Hsu, Ching-Lung Lai, Man-Fung Yuen. Update on the Risk of Hepatocellular Carcinoma in Chronic Hepatitis B Virus InfectionCurrent Hepatitis Reports 2011; 10(2): 106 doi: 10.1007/s11901-011-0094-2
14
Neehar D. Parikh, Sherry Fu, Huiying Rao, Ming Yang, Yumeng Li, Corey Powell, Elizabeth Wu, Andy Lin, Baocai Xing, Lai Wei, Anna S. F. Lok. Risk Assessment of Hepatocellular Carcinoma in Patients with Hepatitis C in China and the USADigestive Diseases and Sciences 2017; 62(11): 3243 doi: 10.1007/s10620-017-4776-7
15
Hung‐Hsien Chiang, Chuan‐Mo Lee, Tsung‐Hui Hu, Chao‐Hung Hung, Jing‐Houng Wang, Sheng‐Nan Lu, Hsueh‐Chou Lai, Wen‐Pang Su, Chia‐Hsin Lin, Cheng‐Yuan Peng, Chien‐Hung Chen. A combination of the on‐treatment FIB‐4 and alpha‐foetoprotein predicts clinical outcomes in cirrhotic patients receiving entecavirLiver International 2018; 38(11): 1997 doi: 10.1111/liv.13889
16
Chao‐Tung Chen, Jing‐Yi Chen, Jing‐Houng Wang, Kuo‐Chin Chang, Po‐Lin Tseng, Kwong‐Ming Kee, Pao‐Fei Chen, Lin‐San Tsai, Shu‐Chuan Chen, Sheng‐Che Lin, Sheng‐Nan Lu. Diabetes mellitus, metabolic syndrome and obesity are not significant risk factors for hepatocellular carcinoma in an HBV‐ and HCV‐endemic area of Southern TaiwanThe Kaohsiung Journal of Medical Sciences 2013; 29(8): 451 doi: 10.1016/j.kjms.2012.12.006
17
Wai Gin Lee, Cameron I. Wells, John L. McCall, Rinki Murphy, Lindsay D. Plank. Prevalence of diabetes in liver cirrhosis: A systematic review and meta‐analysisDiabetes/Metabolism Research and Reviews 2019; 35(6) doi: 10.1002/dmrr.3157
18
Trung Doan Hieu, Chuong Tran Xuan. LIVER FIBROSIS RESPONSE TO ENTECAVIR TREATMENT IN PATIENTS WITH HBV-RELATED COMPENSATED CIRRHOSISJournal of Medicine and Pharmacy 2018; 8(6): 203 doi: 10.34071/jmp.2018.6.27